TOKYO, Mar 30 (Pulse News Wire) – Nihon Trim CO.,LTD. (6788.T) announced the selection of a new director candidate, Shimizu Takafumi, during its board meeting held on March 28, 2026.
The appointment is subject to approval at the upcoming annual shareholders' meeting scheduled for late June 2026. Shimizu joined NIHON TRIM in September 1998 and served as executive officer responsible for overseas operations and corporate planning until his retirement in September 2013. Since then, he has held positions such as vice president at PT. Super Wahana Tehno in Indonesia and CEO of Stem Cell Kenkyuusho.
The company highlighted Shimizu's extensive experience in corporate planning within NIHON TRIM, particularly in the medical field and international business. Additionally, his leadership roles at Stem Cell Institute Corporation, a subsidiary of NIHON TRIM listed on the Tokyo Stock Exchange (code number: 7,096), further bolster his qualifications. NIHON TRIM holds 71.2% of voting rights in Stem Cell Institute Corporation. NIHON TRIM anticipates Shimizu’s formal appointment taking effect in late June 2026, aiming to enhance transparency and strategic decision-making across the group.
🟢 Confidence: High AI-translated content.